Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex.

Wallace CH, Wu BX, Salem M, Ansa-Addo EA, Metelli A, Sun S, Gilkeson G, Shlomchik MJ, Liu B, Li Z.

JCI Insight. 2018 Apr 5;3(7). pii: 99863. doi: 10.1172/jci.insight.99863. [Epub ahead of print]

2.

Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling.

Ansa-Addo EA, Zhang Y, Yang Y, Hussey GS, Howley BV, Salem M, Riesenberg B, Sun S, Rockey DC, Karvar S, Howe PH, Liu B, Li Z.

J Clin Invest. 2017 Apr 3;127(4):1321-1337. doi: 10.1172/JCI89281. Epub 2017 Mar 13.

3.

Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94.

Ansa-Addo EA, Thaxton J, Hong F, Wu BX, Zhang Y, Fugle CW, Metelli A, Riesenberg B, Williams K, Gewirth DT, Chiosis G, Liu B, Li Z.

Curr Top Med Chem. 2016;16(25):2765-78. Review.

4.

GRP94/gp96 in Cancer: Biology, Structure, Immunology, and Drug Development.

Wu BX, Hong F, Zhang Y, Ansa-Addo E, Li Z.

Adv Cancer Res. 2016;129:165-90. doi: 10.1016/bs.acr.2015.09.001. Epub 2015 Sep 28. Review.

PMID:
26916005
5.

Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo.

Jorfi S, Ansa-Addo EA, Kholia S, Stratton D, Valley S, Lange S, Inal J.

Sci Rep. 2015 Aug 25;5:13006. doi: 10.1038/srep13006.

6.

GP96: safeguarding Treg.

Zhang Y, Ansa-Addo E, Li Z.

Oncotarget. 2015 Aug 21;6(24):19936-7. No abstract available.

7.

GP96 is a GARP chaperone and controls regulatory T cell functions.

Zhang Y, Wu BX, Metelli A, Thaxton JE, Hong F, Rachidi S, Ansa-Addo E, Sun S, Vasu C, Yang Y, Liu B, Li Z.

J Clin Invest. 2015 Feb;125(2):859-69. doi: 10.1172/JCI79014. Epub 2015 Jan 20.

8.

Interplay of host-pathogen microvesicles and their role in infectious disease.

Inal JM, Ansa-Addo EA, Lange S.

Biochem Soc Trans. 2013 Feb 1;41(1):258-62. doi: 10.1042/BST20120257. Review.

PMID:
23356293
9.

Microvesicles in health and disease.

Inal JM, Ansa-Addo EA, Stratton D, Kholia S, Antwi-Baffour SS, Jorfi S, Lange S.

Arch Immunol Ther Exp (Warsz). 2012 Apr;60(2):107-21. doi: 10.1007/s00005-012-0165-2. Epub 2012 Feb 4. Review.

PMID:
22307363
10.

Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles.

Cestari I, Ansa-Addo E, Deolindo P, Inal JM, Ramirez MI.

J Immunol. 2012 Feb 15;188(4):1942-52. doi: 10.4049/jimmunol.1102053. Epub 2012 Jan 18.

11.

A filtration-based protocol to isolate human plasma membrane-derived vesicles and exosomes from blood plasma.

Grant R, Ansa-Addo E, Stratton D, Antwi-Baffour S, Jorfi S, Kholia S, Krige L, Lange S, Inal J.

J Immunol Methods. 2011 Aug 31;371(1-2):143-51. doi: 10.1016/j.jim.2011.06.024. Epub 2011 Jun 30.

PMID:
21741384
12.

Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells.

Ansa-Addo EA, Lange S, Stratton D, Antwi-Baffour S, Cestari I, Ramirez MI, McCrossan MV, Inal JM.

J Immunol. 2010 Nov 1;185(9):5236-46. doi: 10.4049/jimmunol.1001656. Epub 2010 Oct 4.

13.

Red cell PMVs, plasma membrane-derived vesicles calling out for standards.

Hind E, Heugh S, Ansa-Addo EA, Antwi-Baffour S, Lange S, Inal J.

Biochem Biophys Res Commun. 2010 Sep 3;399(4):465-9. doi: 10.1016/j.bbrc.2010.07.095. Epub 2010 Jul 30. Review.

PMID:
20674549
14.

Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells--possible role in SLE.

Antwi-Baffour S, Kholia S, Aryee YK, Ansa-Addo EA, Stratton D, Lange S, Inal JM.

Biochem Biophys Res Commun. 2010 Jul 23;398(2):278-83. doi: 10.1016/j.bbrc.2010.06.079. Epub 2010 Jun 23.

PMID:
20599722
15.

Involvement of lectin pathway activation in the complement killing of Giardia intestinalis.

Evans-Osses I, Ansa-Addo EA, Inal JM, Ramirez MI.

Biochem Biophys Res Commun. 2010 May 7;395(3):382-6. doi: 10.1016/j.bbrc.2010.04.025. Epub 2010 Apr 9.

PMID:
20382117

Supplemental Content

Loading ...
Support Center